SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000921895-11-000280
Filing Date
2011-02-14
Accepted
2011-02-14 18:19:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13G sc13ga107422zal_12312010.htm SC 13G/A 197023
  Complete submission text file 0000921895-11-000280.txt   199171
Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 245 FIRST STREET 3RD FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET 3RD FLOOR CAMBRIDGE MA 02142 617-301-7000
Zalicus Inc. (Subject) CIK: 0001135906 (see all company filings)

IRS No.: 043514457 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81444 | Film No.: 11608811
SIC: 2834 Pharmaceutical Preparations